About Zevra Therapeutics, Inc. 
Zevra Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 37 Schemes (24.64%)
Foreign Institutions
Held by 49 Foreign Institutions (8.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
34 Million
(Quarterly Results - Dec 2025)
Net Profit:
12 Million
Pharmaceuticals & Biotechnology
USD 579 Million (Micro Cap)
6.00
NA
0.00%
-1.03
72.30%
4.35






